Generation of muscular dystrophy model rats with a CRISPR/Cas system
- PMID: 25005781
- PMCID: PMC4088098
- DOI: 10.1038/srep05635
Generation of muscular dystrophy model rats with a CRISPR/Cas system
Abstract
Duchenne muscular dystrophy (DMD) is an X-linked lethal muscle disorder caused by mutations in the Dmd gene encoding Dystrophin. DMD model animals, such as mdx mice and canine X-linked muscular dystrophy dogs, have been widely utilized in the development of a treatment for DMD. Here, we demonstrate the generation of Dmd-mutated rats using a clustered interspaced short palindromic repeats (CRISPR)/Cas system, an RNA-based genome engineering technique that is also adaptive to rats. We simultaneously targeted two exons in the rat Dmd gene, which resulted in the absence of Dystrophin expression in the F0 generation. Dmd-mutated rats exhibited a decline in muscle strength, and the emergence of degenerative/regenerative phenotypes in the skeletal muscle, heart, and diaphragm. These mutations were heritable by the next generation, and F1 male rats exhibited similar phenotypes in their skeletal muscles. These model rats should prove to be useful for developing therapeutic methods to treat DMD.
Figures
References
-
- Koenig M., Monaco A. P. & Kunkel L. M. The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell 53, 219–228 (1988). - PubMed
-
- Hoffman E. P., Brown R. H. Jr & Kunkel L. M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51, 919–28 (1987). - PubMed
-
- Vainzof M. et al. Animal models for genetic neuromuscular diseases. J. Mol. Neurosci. 34, 241–248 (2008). - PubMed
-
- Sekiguchi M. et al.. A deficit of brain dystrophin impairs specific amygdala GABAergic transmission and enhances defensive behaviour in mice. Brain 132, 124–135 (2009). - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
